Tamer Coskun
-
- Diabetes Treatment and Management 4
- Pharmacology top 2%
- Pharmacology and Obesity Treatment 3
- Physiology top 10%
- Endocrine and Autonomic Systems top 10%
-
- Metabolism, Diabetes, and Cancer 2
-
- Medical Imaging Techniques and Applications 1
- Cardiac Imaging and Diagnostics 1
-
- Cardiovascular Disease and Adiposity 1
- Cardiovascular Function and Risk Factors 1
-
- Cancer, Hypoxia, and Metabolism 1
Tamer Coskun
5 papers receiving 775 citations
Hit Papers
Peers
Comparison fields: 5 of 65
- Endocrinology, Diabetes and Metabolism 566
- Pharmacology 356
- Physiology 292
- Endocrine and Autonomic Systems 62
- Surgery 157
Countries citing papers authored by Tamer Coskun
This map shows the geographic impact of Tamer Coskun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamer Coskun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamer Coskun more than expected).
Fields of papers citing papers by Tamer Coskun
This network shows the impact of papers produced by Tamer Coskun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamer Coskun. The network helps show where Tamer Coskun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tamer Coskun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2024 | 2 | |
| 5 | Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USAbreakdown → | 2023 | 232 |
| 6 | Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trialbreakdown → | 2023 | 549 |
About Tamer Coskun
Tamer Coskun is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Radiology, Nuclear Medicine and Imaging, having authored 6 papers that have together received 787 indexed citations. Recurring topics across this work include Diabetes Treatment and Management (4 papers), Pharmacology and Obesity Treatment (3 papers), Metabolism, Diabetes, and Cancer (2 papers), Medical Imaging Techniques and Applications (1 paper), Cardiovascular Disease and Adiposity (1 paper), Cardiac Imaging and Diagnostics (1 paper), Cardiovascular Function and Risk Factors (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (566 citations), Pharmacology (356 citations) and Physiology (292 citations). Tamer Coskun has collaborated with scholars based in United States, Sweden and Czechia. Frequent co-authors include Zvonko Miličević, Axel Haupt, Juan P. Frías, Sirel Gurbuz, Mark L. Hartman, Ania M. Jastreboff, Yu Du, Qiwei Wu, Lee M. Kaplan and Jitong Lou. Their work appears in journals such as New England Journal of Medicine, The Lancet and The Lancet Diabetes & Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.